Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Panacea Life Sciences Hldgs Inc Ordinary Shares EXDI

Healthcare Drug Manufacturers - Specialty & Generic
Exactus, Inc is a healthcare company pursuing opportunities in hemp derived Cannabidiol (CBD) products. The company sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities.

Recent & Breaking News (OTCQB:EXDI)

CBD Company Panacea Life Sciences Sees Promise as Denver Airport Reaches Third-Highest Passenger Traffic in World

Accesswire October 29, 2021

Exactus, Inc. Announces Name Change to Panacea Life Sciences Holdings, Inc. and 1 to 28 Reverse Stock Split

Accesswire October 28, 2021

Grand Opening of the Panacea Life Sciences Cannabinoid Research Center at Colorado State University

Accesswire October 14, 2021

22nd Century Announces Restructuring of Panacea Investment, Expansion of Cannabis Franchise Capabilities

GlobeNewswire July 1, 2021

Exactus Joins with Panacea Life Sciences to Create Premier CBD Wellness Platform

Accesswire July 1, 2021

Exactus, Inc. Reports Third Quarter 2020 Financial Results

Accesswire November 19, 2020

Exactus, Inc. Reports Second Quarter 2020 Financial Results and Conference Call

GlobeNewswire August 20, 2020

Exactus, Inc. Reports First Quarter 2020 Financial Results

GlobeNewswire July 1, 2020

Exactus Appoints Leading Business Expert, Julian Pittam to Chairman of the Board of Directors

GlobeNewswire June 15, 2020

Exactus Announces its Hemp Seed Buyback Program to Assist Farmers Impacted by the COVID-19 Pandemic

GlobeNewswire May 28, 2020

Exactus, Inc. Reports 2019 Year End Results

GlobeNewswire May 26, 2020

Exactus Appoints Technology Expert Mark Alouf to Its Advisory Board

GlobeNewswire May 12, 2020

Exactus Announces the Promotion of Derek Du Chesne as Company President and appointment to the Board of Directors

GlobeNewswire May 11, 2020

Exactus Appoints Co-Founder of Rokt Justin Viles to its Board of Directors

GlobeNewswire May 8, 2020

Exactus Appoints Former Broadcast Media Executive Larry Wert to Its Board of Directors

GlobeNewswire May 4, 2020

CORRECTION -- Exactus, Inc. Launches a Genetics Division to Supply Farmers with USDA Compliant Feminized CBD and CBG Hemp Seeds

GlobeNewswire April 28, 2020

Exactus, Inc. Launches a Genetics Division to Supply Farmers with FDA Compliant Feminized CBD and CBG Hemp Seeds

GlobeNewswire April 28, 2020

2019 Annual Shareholder Letter

GlobeNewswire March 4, 2020

Exactus Inc. appoints Derek Du Chesne as Chief Growth Officer and announces Company to present at NobleCon16

GlobeNewswire February 18, 2020

Exactus, Inc. Enters into Supply & Distribution Agreement with Hemptown USA

GlobeNewswire February 4, 2020